New - European Medical Journal

Continue

News

EMJ
Gastroenterology
26 Sep 2016

Nanotechnology Applied to Ginger Offers Novel Treatment for Bowel Disease

NANOPARTICLES derived from ginger have been used to produce a beneficial effect in the treatment of inflammatory bowel disease (IBD), offering a novel…
Rheumatology
23 Sep 2016

EFIC Symposium: New Therapeutic Strategies to Combat Joint Pain

Dubrovnik, September 23, 2016 – Joint pain continues to be one of the main reasons for persisting disablement. One explanation, among others, is that…
Rheumatology
22 Sep 2016

EFIC Symposium: Chronic Pain Following Joint Surgery – Experts Call for New Approaches

Dubrovnik, September 22, 2016 – Many patients are disappointed and dissatisfied when they find they are still experiencing pain in the months and years…
Rheumatology
22 Sep 2016

EFIC Symposium: Myths and Facts About Joint Pain

Dubrovnik, September 21, 2016 – A lot of incorrect assumptions about joint pain are in circulation. “The sometimes overly pessimistic misconceptions can…
Neurology
21 Sep 2016

Merck Presents New Data on the Safety and Durable Efficacy of Cladribine Tablets and Advantages of Early Treatment with Rebif® at the 2016 ECTRIMS Congress

Germany, September 12, 2016 – Merck, a leading science and technology company, today announced key symposia and more than 30 presentations of clinical…
Cardiology
20 Sep 2016

Janssen Receives CHMP Positive Opinion for STELARA® (Ustekinumab) Recommending Approval for the Treatment of Moderately to Severely Active Crohn’s Disease in the European Union

Belgium, September 16, 2016 – Janssen-Cilag International NV (“Janssen”) announced today that the Committee for Medicinal Products for Human Use (CHMP)…
EMJ
Innovations
19 Sep 2016

Scientists Mobilise Nanorobots to Fight Against Cancer

SWARMS of magneto-aerotactic bacteria equipped with covalently-bound drug-containing nanoliposomes have been administered into the bloodstream to…
EMJ
Hematology
19 Sep 2016

CRISPR Genome Editing Allows Blood Cells to Resist Sickle Cell Disease

INNOVATIVE CRISPR genome editing has been used to inhibit the pathological morphology of red blood cells caused by sickle cell disease, offering a new…